Rita Mencucci1, Ugo Menchini, Rosanna Dei. 1. Department of Oto-Neuro-Opthalmological Surgical Sciences, University of Florence, Florence, Italy. rita.mencucci@unifi.it
Abstract
PURPOSE: To investigate if amniotic membrane incubated with antibiotics could inhibit bacterial growth in vitro. METHODS: Amniotic membrane fragments were incubated with the antibiotics (netilmicin) solution; the washed and drained fragments were either tested after treatment or further incubated in antibiotic-free medium. The antibacterial activity of both amniotic membrane and elution media was carried out by the Agar diffusion method, with Staphylococcus epidermidis as indicator, measuring the inhibition zone after overnight incubation. RESULTS: The amniotic membrane fragments soaked in antibiotics inhibited bacterial growth. Antibiotic uptake was dose-dependent and occurred rapidly. The drug was released from the membrane, and the antibacterial effect was present in the elution media at least 3 days after treatment. CONCLUSIONS: Our preliminary in vitro data show that amniotic membrane can absorb the antibiotic netilmicin and in the future may be used to deliver antibiotics, as reported for collagen shields and other medical prosthetic devices.
PURPOSE: To investigate if amniotic membrane incubated with antibiotics could inhibit bacterial growth in vitro. METHODS: Amniotic membrane fragments were incubated with the antibiotics (netilmicin) solution; the washed and drained fragments were either tested after treatment or further incubated in antibiotic-free medium. The antibacterial activity of both amniotic membrane and elution media was carried out by the Agar diffusion method, with Staphylococcus epidermidis as indicator, measuring the inhibition zone after overnight incubation. RESULTS: The amniotic membrane fragments soaked in antibiotics inhibited bacterial growth. Antibiotic uptake was dose-dependent and occurred rapidly. The drug was released from the membrane, and the antibacterial effect was present in the elution media at least 3 days after treatment. CONCLUSIONS: Our preliminary in vitro data show that amniotic membrane can absorb the antibiotic netilmicin and in the future may be used to deliver antibiotics, as reported for collagen shields and other medical prosthetic devices.
Authors: Sumayya Ahmad; Michelle Lopez; Marwan Attala; Anat Galor; Natalie A Stanciu; Darlene Miller; Leejee Suh; Thomas Albini; Victor L Perez; Carol L Karp; Janet L Davis; Eduardo Alfonso; Richard K Forster; Guillermo Amescua Journal: Ocul Immunol Inflamm Date: 2017-10-17 Impact factor: 3.070
Authors: Tobias Röck; Karl Ulrich Bartz-Schmidt; Johanna Landenberger; Matthias Bramkamp; Daniel Röck Journal: Ann Transplant Date: 2018-03-06 Impact factor: 1.530
Authors: Han Y Yin; Anny M S Cheng; Sean Tighe; Philip Kurochkin; Jamie Nord; Swetha Dhanireddy; Robert Swan; Samuel Alpert Journal: Sci Rep Date: 2020-10-12 Impact factor: 4.379